Literature DB >> 77814

Studies on factor XIII antigen in congenital factor XIII deficiency. A tentative classification of the disease in two groups.

A Girolami, A Burul, F Fabris, G Cappellato, C Betterle.   

Abstract

Immunological and immunofluorescent studies carried out on plasma and platelets of three cases of congenital factor XIII deficiency are reported. Two of these patients were originally thought to have normal factor XIII subunit S and no subunit A. However, repeated assays carried out using different lots of antiserum showed that in reality the patients lacked both subunit S and subunit A. The false positive finding was due to the presence of a anti-factor VIII contaminant in the antiserum originally used. The third patient had a normal subunit S and no subunit A. No factor XIII antigen was found by the indirect immunofluorescent technique in normal, factor XIII deficiency and von Willebrand's disease platelets. On the contrary, by using the non-monospecific antiserum a fluorescent pattern similar to that observed by using an anti-factor VIII antiserum, had been noted. On the basis of the data presented in this paper a tentative classification of factor XIII deficiency in two groups is proposed: Type I is characterized by the lack of both factor XIII subunit S and A. Type II is characterized by a normal subunit S and no subunit A. The need for a re-evaluation of published case of factor XIII deficiency by means of monospecific antisera is indicated.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 77814

Source DB:  PubMed          Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch        ISSN: 0323-4347


  8 in total

1.  Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5' end of exon III.

Authors:  T Kamura; T Okamura; M Murakawa; H Tsuda; T Teshima; T Shibuya; M Harada; Y Niho
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Localization of the coagulation factor XIII B subunit gene (F13B) to chromosome bands 1q31-32.1 and restriction fragment length polymorphism at the locus.

Authors:  G C Webb; M Coggan; A Ichinose; P G Board
Journal:  Hum Genet       Date:  1989-01       Impact factor: 4.132

3.  Type I and type II disease in congenital factor XIII deficiency. A further demonstration of the correctness of the classification.

Authors:  A Girolami; M G Cappellato; A R Lazzaro; M Boscaro
Journal:  Blut       Date:  1986-11

4.  Genetic polymorphism of the B subunit of human coagulation factor XIII.

Authors:  P G Board
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

5.  Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression.

Authors:  Yusuke Inoue; Luanne L Peters; Sun Hee Yim; Junko Inoue; Frank J Gonzalez
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

6.  Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice.

Authors:  Masayoshi Souri; Shiori Koseki-Kuno; Naoki Takeda; Jay L Degen; Akitada Ichinose
Journal:  Int J Hematol       Date:  2007-12-05       Impact factor: 2.490

7.  Molecular and cellular basis of deficiency of the b subunit for factor XIII secondary to a Cys430-Phe mutation in the seventh Sushi domain.

Authors:  T Hashiguchi; A Ichinose
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

8.  Factor XIII B subunit polymorphisms and the risk of coronary artery disease.

Authors:  Zoltán A Mezei; Zsuzsanna Bereczky; Éva Katona; Réka Gindele; Emília Balogh; Szilvia Fiatal; László Balogh; István Czuriga; Róza Ádány; István Édes; László Muszbek
Journal:  Int J Mol Sci       Date:  2015-01-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.